WRN helicase inhibition by HRO761 was sufficient to impair the viability of MSI cancer cells with GI50 values in the range of 50–1,000 nM, while there was no effect in microsatellite-stable (MSS) cells in a 10-to-14-day clonogenic assay. The gene discussed is WRN; the disease is cancer.